Topoisomerase IIα as a prognostic factor in mantle cell lymphoma
- 17 June 2004
- journal article
- editorial
- Published by Springer Nature in Leukemia
- Vol. 18 (8) , 1347-1349
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Topoisomerase IIα expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcomeLeukemia, 2004
- Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disordersLeukemia, 2004
- Mantle cell lymphoma: established therapeutic options and future directionsAnnals of Hematology, 2004
- Long‐term follow‐up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remissionCancer, 2003
- A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal diseaseBlood, 2003
- A Danish population-based analysis of 105 mantle cell lymphoma patientsEuropean Journal of Cancer, 2002
- Predictive value of topoisomerase IIα and other prognostic factors for epirubicin chemotherapy in advanced breast cancerBritish Journal of Cancer, 1998
- Mantle cell lymphomaCancer, 1998
- A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's LymphomaBlood, 1997
- Patterns of survival in mantle cell lymphomaAnnals of Oncology, 1995